Malignant Female Reproductive System Neoplasm

Malignant Female Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,254 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,464
Recruiting: 821
Ph III recruiting: 96
Growth YoY: +6%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (740)

clinicaltrialsPublishedShowing 151–200 of 581 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03400826	Effects of Simvastatin on Uterine Leiomyoma Size	active not recruiting	Phase 2	60	Johns Hopkins UniversityOTHER	1	Jul 21, 2026	clinicaltrials
NCT04918186	Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer(IPROC)	recruiting	Phase 2	60	Canadian Cancer Trials GroupNETWORK	2	Jul 21, 2026	clinicaltrials